Funder: Andy Hill Cancer Research Endowment (CARE Fund)
Due Dates (Anticipated): March 2027 (Application deadline)
Funding Amounts: Past cycle: $250,000–$1,500,000 over up to two years, with a 1:1 non-state match
Summary: Supports innovative cancer discovery and validation research advancing prevention, diagnosis, treatment, patient outcomes, and quality of life.
Key Information: Applicants must have a substantial Washington presence and allocate at least 75% of both grant and matching funds to Washington research.
Description
The Andy Hill Cancer Research Endowment (CARE Fund) supports cancer researchers at all career levels and teams pursuing scientific discoveries and breakthrough ideas. The program prioritizes basic research, discovery, and validation that could improve prevention and early detection, diagnosis and treatment, or patient outcomes and quality of life. Supported work may investigate cancer mechanisms, validate novel interventions or new uses of established interventions, and develop technologies or therapies through proof-of-concept or feasibility studies.
High-risk projects are welcome when they offer potential for high-impact advances beyond the project period. Population-based research examining biological, behavioral, environmental, social, and structural influences on cancer-related health is encouraged, including research on social determinants of health. The program spans etiology through survivorship and may help bridge early discoveries and commercialization; implementation-focused work is better suited to other CARE Fund opportunities.
